Skip to main content
. 2022 Dec 6;11(23):e026388. doi: 10.1161/JAHA.121.026388

Table 5.

C‐Statistics for HAS‐BLED Score Against ICH, According to Each Cancer Type

Type of cancer No. of patients (descending order) C‐statistic (95% CI) for ICH
HAS‐BLED score continuous HAS‐BLED score ≥3
All cancers 399 344 0.74 (0.74–0.75) 0.70 (0.69–0.70)
Metastatic cancer 97 606 0.75 (0.73–0.76) 0.71 (0.69–0.72)
Prostatic cancer 62 710 0.72 (0.71–0.73) 0.67 (0.67–0.68)
Colorectal cancer 54 755 0.74 (0.73–0.75) 0.69 (0.68–0.70)
Lung cancer 49 737 0.75 (0.73–0.76) 0.70 (0.68–0.72)
Breast cancer 38 699 0.80 (0.79–0.81) 0.75 (0.74–0.76)
Bladder cancer 32 342 0.69 (0.67–0.71) 0.64 (0.63–0.65)
Leukemia 19 148 0.70 (0.68–0.72) 0.66 (0.65–0.68)
Lymphoma 17 986 0.74 (0.72–0.76) 0.71 (0.69–0.72)
Renal cancer 13 294 0.71 (0.68–0.74) 0.64 (0.63–0.66)
Myeloma 13 081 0.71 (0.69–0.74) 0.67 (0.64–0.69)
Liver cancer 9261 0.69 (0.65–0.73) 0.61 (0.59–0.63)
Gastric cancer 8470 0.75 (0.71–0.79) 0.70 (0.67–0.74)
Pancreas cancer 8409 0.78 (0.75–0.82) 0.74 (0.71–0.77)
Uterine cancer 7670 0.74 (0.70–0.78) 0.69 (0.66–0.72)
Ovarian cancer 4494 0.79 (0.73–0.84) 0.73 (0.68–0.78)

HAS‐BLED indicates uncontrolled hypertension (systolic blood pressure >160 mm Hg), abnormal kidney (dialysis or transplant)/liver function (ie, cirrhosis), previous stroke, bleeding history or predisposition, elderly age (≥65 years), and drug (antiplatelet, nonsteroidal anti‐inflammatory drugs)/alcohol abuse; and ICH, intracranial hemorrhage.